Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing cardiac arrhythmia market.
Joined January 2020
- Tweets 63
- Following 174
- Followers 1,155
- Likes 23
6 Photos and videos
Medtronic receives CE mark approval for the Affera™ Mapping and Ablation System! Find the latest on Affera technologies and clinical programs by following us at @MDT_EPAblation and @medtroniceu #EPeeps #afferaCEmark #affera
15 Mar 2023
Affera™ mapping and ablation system, which includes the Sphere-9™ all-in-one mapping and therapeutic radiofrequency (RF) and pulsed field (PF) ablation catheter, receives CE Mark approval! bit.ly/3YQHAD8
1
10
35
10,446
Affera retweeted
26 Apr 2023
Thrilled the first Affera System case took place at Medical Center Hamburg-Eppendorf. Congrats to @AndreasMetzner7 & team. This is the first of sites to come in the next few weeks. Excited to make a difference for patients with this novel innovation #MedtronicEmployee #EPeeps
26 Apr 2023
Thrilled to share that we are the first center worldwide who performed ablation procedures with the Medtronic Affera Mapping and Ablation system! Congratulations to our great team and Medtronic, great achievement!
#Affera #PFA #innovationinhealthcare #electrophysiology #EPeeps
6
34
9,712
Affera retweeted
24 Apr 2023
Just published! The Affera™ Mapping and Ablation System 12-month outcomes that led to CE Mark were just published in @JACCJournals. Read it now: bit.ly/3oC4F03
11
40
7,223
Keep up with Affera technologies and clinical programs via Medtronic Channels: @MDT_Cardiac and @MDT_StructHeart starting today!
2
5
43
Affera retweeted
14 Jun 2022
Thoughts after first cases w Affera: 1) having all in one mapping/ablating globe is super efficient (mapped an LAA AT and two SVC ATs on first case- first burn terminations on all three) 2) mapping definition and annotation algorithm is on the money as evidenced above
1
5
52
Affera retweeted
15 Feb 2022
I am fortunate to be a site prinicipal investigator for AFFERA's disruptive pulse-field/radiofrequency atrial fibrillation ablation clinical trial. The cardiac electrophysiology community across the world is looking forward to this trial. I had our cent…lnkd.in/e36Sdvyc
7
35
Thank you Drs @EladAnter, Taigen et al. @ClevelandClinic, @natale_md , Burkhardt et al. @tcainstitute and @MoussaMansour10 et al. @harvardmed for a busy and exciting week for @AfferaEP SPHERE PersAF trial!
2
11
59
This is an exciting day for the Affera, Inc. team. Looking forward to partnering with @Medtronic to improve therapies for cardiac arrhythmia patients worldwide.
prnewswire.com/news-releases…
5
10
84
First patient treated in US IDE SPHERE PerAF at @MountSinaiNYC by Drs. @VivekReddyMD @jskoruth @billwhangep and others. Affera also announces $75M series C with Bain Capital Life Sciences.
prnewswire.com/news-releases…
7
44
Affera retweeted
16 Dec 2021
#EPeeps - SinaiNYC- having fun and hoping to improve efficacy and safety
5
7
42
Affera retweeted
28 Sep 2021
*New Research Article* - Pulsed-Field Ablation in Ventricular Myocardium Using a Focal Catheter @eladanter #AHAJournals #Epeeps doi.org/10.1161/CIRCEP.121.0…
16
36
30 Aug 2021
Pulse-field ablation in the ventricle: In contrast to biophysics of RFA, lesion repetition of PFA has incremental effect on lesion dimensions, likely via a mechanism of permeability preconditioning. Congrats to @yavin_h ahajournals.org/doi/abs/10.1… @CirculationEP @ClevelandClinic
1
3
9
Affera retweeted
29 Jul 2021
Dose dependent reversible electroporation - effect on AV node conduction. Follow up from last years data on egm amplitude - transient AV block after the pulse that reverses in <1-2 minutes
1
4
27
Affera, Inc. Announces Successful First-In-Human Use Of SpherePVI Circumferential Pulmonary Vein Isolation Device ... prn.to/3zGJ3jj
2
17
Affera ready to redefine another catheter ablation category. Thank you Drs. Aidietis and Račkauskas at Vilnius University Hospital for hosting us and @EladAnter and @VivekReddyMD for joining us to perform successful FIH procedures last week. Stay tuned…
7
46
Affera retweeted
6 Mar 2021
Another PerAF case with Affera PFA: PVI PWI MAL: 1st to last lesion <30min with total procedure time <1Hr including mapping and 20min waiting period (no reconnections). We may soon be ready to re-evaluate ablation strategies to treat different types of AF w/ rapid and durable Tx.
1
30
159
Affera retweeted
2 Mar 2021
Persistent AF case with Affera: PVI Mitral Line PWI CTI with transpired therapy time of 30 min. Multiple cases, durable lines, consistent results. High-Res mapping and PFA/RFA from the same lattice catheter at a switch of a button. Exciting times to be in EP and Cleveland Clinic
11
31
182
3
3
Affera retweeted
29 Jan 2021
Excellent result with RF/PF ablation using the lattice tip catheter at LBCT #AFSymposium2021
4
20